Health Canada drug identification number

DIN 02419106 — COMBIVENT RESPIMAT 100 MCG; 20 MCG

COMBIVENT RESPIMAT is a solution of Ipratropium / Salbutamol marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Ipratropium / Salbutamol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02419106
Brand name
COMBIVENT RESPIMAT
Active ingredient
Ipratropium / Salbutamol
Strength
100 MCG; 20 MCG
Dosage form
SOLUTION
Route
INHALATION
Manufacturer
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada status
MARKETED
Drug class
Anticholinergic bronchodilator / short-acting beta2-agonist combination

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ipratropium / Salbutamol products

DINBrandStrengthFormManufacturerStatus
02266393 APO-SALVENT-IPRAVENT STERULES 2.5 MG; 0.5 MG SOLUTION APOTEX INC DORMANT
02483394 IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION 0.5 MG; 2.5 MG SOLUTION JUNO PHARMA CANADA INC. MARKETED
02272695 TEVA-COMBO STERINEBS 2.5 MG; 0.5 MG SOLUTION TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.